Abstract
The results of studies to evaluate the possible importance of serratia proteases in the development of experimental Serratia marcescens pneumonia revealed the following. (i) Administration of a highly purified serratia protease to the lungs of guinea pigs and mice resulted in extensive pulmonary edema and hemorrhage similar to that observed in animals having an experimentally induced, acute serratia pneumonia. (ii) Guinea pigs subcutaneously vaccinated with the protease developed low levels of antiprotease antibodies and were partially protected against serratia pneumonia, as demonstrated by a significant increase in survival time. Mice intranasally vaccinated with the protease also developed antiprotease antibodies and were protected against serratia pneumonia, as demonstrated by a significant increase in survival time and an increase in the number of survivors. (iii) Serratia protease was detected in lung tissue extracts prepared from the lungs of guinea pigs dying of serratia pneumonia. Our findings support the idea that serratia protease(s) is involved in the pathogenesis of experimental serratia pneumonia.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cabrera H. A. An outbreak of Serratia marcescens, and its control. Arch Intern Med. 1969 Jun;123(6):650–655. [PubMed] [Google Scholar]
- Homma J. Y., Abe C., Tanamoto K., Hirao Y., Morihara K., Tsuzuki H., Yanagawa R., Honda E., Aoi Y., Fujimoto Y. Effectiveness of immunization with single and multi-component vaccines prepared from a common antigen (OEP), protease and elastase toxoids of Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink due to P. aeruginosa. Jpn J Exp Med. 1978 Apr;48(2):111–133. [PubMed] [Google Scholar]
- Homma J. Y., Tomiyama T., Sano H., Hirao Y., Saku K. Passive hemagglutination reaction test using formalinized sheep erythrocytes treated with tannic acid and coated with proteast or elastase of Pseudomonas aeruginosa. Jpn J Exp Med. 1975 Oct;45(5):361–365. [PubMed] [Google Scholar]
- Klinger J. D., Straus D. C., Hilton C. B., Bass J. A. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay. J Infect Dis. 1978 Jul;138(1):49–48. doi: 10.1093/infdis/138.1.49. [DOI] [PubMed] [Google Scholar]
- Lyerly D., Kreger A. Purification and characterization of a Serratia marcescens metalloprotease. Infect Immun. 1979 May;24(2):411–421. doi: 10.1128/iai.24.2.411-421.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McCormack R. C., Kunin C. M. Control of a single source nursery epidemic due to Serratia marcescens. Pediatrics. 1966 May;37(5):750–755. [PubMed] [Google Scholar]
- Meltz D. J., Grieco M. H. Characteristics of Serratia marcescens pneumonia. Arch Intern Med. 1973 Sep;132(3):359–364. [PubMed] [Google Scholar]
- Merritt G. C., Egerton J. R. IgG1 and IgG2 immunoglobulins to Bacteroides (Fusiformis) nodosus protease in infected and immunized sheep. Infect Immun. 1978 Oct;22(1):1–4. doi: 10.1128/iai.22.1.1-4.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miyata K., Tsuda M., Tomoda K. Determination of Serratia protease by radioimmunoassay. Anal Biochem. 1980 Jan 15;101(2):332–338. doi: 10.1016/0003-2697(80)90196-7. [DOI] [PubMed] [Google Scholar]
- Sanders C. V., Jr, Luby J. P., Johanson W. G., Jr, Barnett J. A., Sanford J. P. Serratia marcescens infections from inhalation therapy medications: nosocomial outbreak. Ann Intern Med. 1970 Jul;73(1):15–21. doi: 10.7326/0003-4819-73-1-15. [DOI] [PubMed] [Google Scholar]